Burning Rock Biotech Limited (BNR)
USD 2.95
(0.34%)
USD 2.95
(0.34%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 1.04 Billion CNY | -34.49% |
| 2022 | 1.58 Billion CNY | -30.33% |
| 2021 | 2.27 Billion CNY | -14.44% |
| 2020 | 2.66 Billion CNY | 214.2% |
| 2019 | 847.55 Million CNY | 127.43% |
| 2018 | 372.67 Million CNY | -6.91% |
| 2017 | 400.33 Million CNY | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q2 | 1.02 Billion CNY | 3.9% |
| 2024 Q1 | 984.92 Million CNY | -5.3% |
| 2023 Q2 | 1.33 Billion CNY | -6.11% |
| 2023 FY | 1.04 Billion CNY | -34.49% |
| 2023 Q4 | 1.04 Billion CNY | -10.86% |
| 2023 Q3 | 1.16 Billion CNY | -12.33% |
| 2023 Q1 | 1.41 Billion CNY | -10.72% |
| 2022 Q4 | 1.58 Billion CNY | -8.31% |
| 2022 Q3 | 1.73 Billion CNY | -6.98% |
| 2022 Q2 | 1.86 Billion CNY | -11.7% |
| 2022 FY | 1.58 Billion CNY | -30.33% |
| 2022 Q1 | 2.1 Billion CNY | -7.5% |
| 2021 Q2 | 2.53 Billion CNY | -5.33% |
| 2021 Q4 | 2.27 Billion CNY | -6.09% |
| 2021 FY | 2.27 Billion CNY | -14.44% |
| 2021 Q3 | 2.42 Billion CNY | -4.46% |
| 2021 Q1 | 2.68 Billion CNY | 0.73% |
| 2020 Q1 | 1.06 Billion CNY | 26.13% |
| 2020 Q4 | 2.66 Billion CNY | -4.98% |
| 2020 Q3 | 2.8 Billion CNY | -4.73% |
| 2020 FY | 2.66 Billion CNY | 214.2% |
| 2020 Q2 | 2.94 Billion CNY | 175.16% |
| 2019 Q1 | - CNY | -100.0% |
| 2019 Q3 | 898.62 Million CNY | 0.0% |
| 2019 FY | 847.55 Million CNY | 127.43% |
| 2019 Q4 | 847.55 Million CNY | -5.68% |
| 2018 Q4 | 372.67 Million CNY | 0.0% |
| 2018 FY | 372.67 Million CNY | -6.91% |
| 2017 FY | 400.33 Million CNY | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Aclaris Therapeutics, Inc. | 197.4 Million USD | -426.836% |
| Applied DNA Sciences, Inc. | 13.65 Million USD | -7518.175% |
| Aspira Women's Health Inc. | 6.26 Million USD | -16508.128% |
| Biodesix, Inc. | 99.09 Million USD | -949.488% |
| BioNexus Gene Lab Corp. | 11.39 Million USD | -9022.981% |
| bioAffinity Technologies, Inc. | 8.22 Million USD | -12549.692% |
| bioAffinity Technologies, Inc. | 8.22 Million USD | -12549.692% |
| Bionano Genomics, Inc. | 214.4 Million USD | -385.066% |
| CareDx, Inc | 484.61 Million USD | -114.604% |
| Check-Cap Ltd. | 25.01 Million USD | -4057.177% |
| Castle Biosciences, Inc. | 477.81 Million USD | -117.659% |
| DarioHealth Corp. | 96.38 Million USD | -978.962% |
| Exact Sciences Corporation | 6.47 Billion USD | 83.929% |
| Fulgent Genetics, Inc. | 1.27 Billion USD | 18.31% |
| Guardant Health, Inc. | 1.78 Billion USD | 41.783% |
| ICON Public Limited Company | 16.98 Billion USD | 93.879% |
| IDEXX Laboratories, Inc. | 3.25 Billion USD | 68.097% |
| Illumina, Inc. | 10.11 Billion USD | 89.714% |
| Intelligent Bio Solutions Inc. | 13.77 Million USD | -7447.8% |
| iSpecimen Inc. | 15.81 Million USD | -6474.322% |
| Standard BioTools Inc. | 323.06 Million USD | -221.915% |
| MDxHealth SA | 129.13 Million USD | -705.378% |
| 23andMe Holding Co. | 395.16 Million USD | -163.18% |
| Medpace Holdings, Inc. | 1.65 Billion USD | 37.229% |
| Myriad Genetics, Inc. | 1.19 Billion USD | 13.239% |
| Mainz Biomed B.V. | 15.4 Million USD | -6649.297% |
| ENDRA Life Sciences Inc. | 6.75 Million USD | -15297.964% |
| NeoGenomics, Inc. | 1.68 Billion USD | 38.14% |
| Neogen Corporation | 4.58 Billion USD | 77.313% |
| Inotiv, Inc. | 856.53 Million USD | -21.42% |
| Natera, Inc. | 1.45 Billion USD | 28.627% |
| OpGen, Inc. | 1.88 Million USD | -55152.37% |
| OPKO Health, Inc. | 2.01 Billion USD | 48.302% |
| Psychemedics Corporation | 13.27 Million USD | -7737.234% |
| Prenetics Global Limited | 254.17 Million USD | -309.175% |
| Prenetics Global Limited | 254.17 Million USD | -309.175% |
| Precipio, Inc. | 18.1 Million USD | -5645.544% |
| Personalis, Inc. | 225.09 Million USD | -362.019% |
| RadNet, Inc. | 2.88 Billion USD | 63.973% |
| Sera Prognostics, Inc. | 95.44 Million USD | -989.679% |
| Sotera Health Company | 3.13 Billion USD | 66.778% |
| Neuronetics, Inc. | 115.83 Million USD | -797.861% |
| Star Equity Holdings, Inc. | 86.97 Million USD | -1095.761% |
| Star Equity Holdings, Inc. | 86.97 Million USD | -1095.761% |
| Trinity Biotech plc | 59.43 Million USD | -1649.812% |
| T2 Biosystems, Inc. | 34.79 Million USD | -2888.766% |
| Twist Bioscience Corporation | 776.4 Million USD | -33.951% |
| Exagen Inc. | 56.94 Million USD | -1726.357% |